Back to Janus Henderson Group Ltd. Janus Henderson Group Ltd.

FL3

14 quarters

Position history for Janus Henderson Group Ltd.Janus Henderson Group Ltd.'s holdings in AVADEL PHARMACEUTICALS PLC

As of its Q1 2024 13F, Janus Henderson held 12,915,160 shares of FL3 (Avadel Pharmaceuticals), worth $218.2M. Janus Henderson's 13F filings listed FL3 from Q4 2022 to Q1 2024, 6 quarterly filings. FL3 was 0.1% of Janus Henderson's reported 13F portfolio.

Final Value

$0

Final Shares

0

Total Value Change

-$1.5M

Total Shares Change

-229,402

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2024-Q2
Latest
Exited
0
-100.0%
$00.0%—
0
2024-Q1
Increased
12.9M
+16.1%
$218.2M0.1%—
42
2023-Q4
Increased
11.1M
+4.6%
$157.1M0.1%—
32
2023-Q3
Increased
10.6M
+41.4%
$109.6M0.1%—
40
2023-Q2
Increased
7.5M
+10.2%
$124M0.1%—
33
2023-Q1
Increased
6.8M
+465.4%
$62.5M0.0%—
48
2022-Q4
New
1.2M
-
$8.6M0.0%—
38
2022-Q2
Exited
0
-100.0%
$00.0%—
0
2022-Q1
Increased
1.4M
+40.6%
$9.6M0.0%—
37
2021-Q4
Increased
1M
+23.7%
$8.1M0.0%—
33
2021-Q3
Increased
811,257
+9.2%
$7.9M0.0%—
30
2021-Q2
Increased
742,772
+193.3%
$5M0.0%—
43
2021-Q1
Increased
253,227
+10.4%
$2.3M0.0%—
29
2020-Q4
New
229,402
-
$1.5M0.0%—
35

Other major holders of FL3: RTW Investments, LP, Polar Capital Holdings Plc

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used